Metis Global Partners, LLC Royalty Pharma PLC Transaction History
Metis Global Partners, LLC
- $2.87 Billion
- Q2 2024
A detailed history of Metis Global Partners, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Metis Global Partners, LLC holds 19,611 shares of RPRX stock, worth $553,030. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,611
Previous 13,546
44.77%
Holding current value
$553,030
Previous $411,000
25.79%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
398Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.24 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$649 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$461 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$338 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...